Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02755064 · ClinicalTrials.gov registry record · Phase 1
Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus
A Phase 1 study, sponsored by Adil Bharucha.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT02755064 is a Phase 1 study that has completed, run by Adil Bharucha. The registered enrollment target is 30 participants.
The verdict
NCT02755064, a Phase 1 study, has completed, sponsored by Adil Bharucha.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
With this study, the investigators hoped to learn if the rate at which food empties from the stomach affects blood sugar values. Using data from this study, we hope to improve our ability to control blood sugars in individuals with type 1 diabetes mellitus.
Interventions
- DRUG Placebo IV
- DRUG Placebo Suspension
- DRUG Erythromycin lactobionate
- DRUG [13C]-Spirulina
- DRUG Erythromycin Ethylsuccinate Suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02755064
The ClinicalTrials.gov registry entry for NCT02755064 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adil Bharucha, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo IV is the first listed.
NCT02755064 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02755064 about?
NCT02755064 is a clinical study titled "Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus". With this study, the investigators hoped to learn if the rate at which food empties from the stomach affects blood sugar values. Using data from this study, we hope to improve our ability to control blood sugars in individuals with type 1 diabetes mellitus.
What is the current status of trial NCT02755064?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2010-06. Estimated completion is 2013-11.
What interventions are being tested in trial NCT02755064?
The interventions under investigation include: Placebo IV (DRUG), Placebo Suspension (DRUG), Erythromycin lactobionate (DRUG), [13C]-Spirulina (DRUG), Erythromycin Ethylsuccinate Suspension (DRUG).
Who is sponsoring clinical trial NCT02755064?
This trial is sponsored by Adil Bharucha, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.